129 related articles for article (PubMed ID: 35575662)
1. Risk factors for poor ovarian response in patients receiving in-vitro fertilization and embryo transfer.
Chen Z; Huang G; Pan L; Yang C; Luo X
Minerva Surg; 2023 Jun; 78(3):303-304. PubMed ID: 35575662
[No Abstract] [Full Text] [Related]
2. Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis.
Bosdou JK; Venetis CA; Tarlatzis BC; Grimbizis GF; Kolibianakis EM
Hum Reprod; 2019 Mar; 34(3):491-505. PubMed ID: 30689865
[TBL] [Abstract][Full Text] [Related]
3. Retraction of: "Risk factors for poor ovarian response in patients receiving in-vitro fertilization and embryo transfer".
Chen Z; Huang G; Pan L; Yang C; Luo X
Minerva Surg; 2024 Aug; 79(4):511. PubMed ID: 38953760
[TBL] [Abstract][Full Text] [Related]
4. Effects of high progesterone on outcomes of in vitro fertilization-embryo transfer in patients with different ovarian responses.
Li PF; Zhu H; Tan L; Zhao DM; Ma LY; Xiang YG; Zhang D; Dou Q; Lu N
Syst Biol Reprod Med; 2015 Jun; 61(3):161-7. PubMed ID: 25915151
[TBL] [Abstract][Full Text] [Related]
5. Bilateral salpingectomy does not compromise ovarian stimulation in an in-vitro fertilization/embryo transfer programme.
Verhulst G; Vandersteen N; van Steirteghem AC; Devroey P
Hum Reprod; 1994 Apr; 9(4):624-8. PubMed ID: 8046013
[TBL] [Abstract][Full Text] [Related]
6. The poor-responder patient in an in vitro fertilization-embryo transfer (IVF-ET) program.
Ben-Rafael Z; Orvieto R; Feldberg D
Gynecol Endocrinol; 1994 Dec; 8(4):277-86. PubMed ID: 7709768
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovarian syndrome: pregnancy outcome following in vitro fertilization-embryo transfer.
Alcalay M; Bider D; Lipitz S; Mashiach S; Levran D; Dor J
Gynecol Endocrinol; 1995 Jun; 9(2):119-23. PubMed ID: 7502687
[TBL] [Abstract][Full Text] [Related]
8. Ovarian pregnancy following in-vitro fertilization and embryo transfer.
Rizk B; Lachelin GC; Davies MC; Hartshorne GM; Edwards RG
Hum Reprod; 1990 Aug; 5(6):763-4. PubMed ID: 2254412
[No Abstract] [Full Text] [Related]
9. Comparison of in vitro fertilization results in women with one or two ovaries.
Dodson MG; Young RL; Poindexter AN; Gibbons WE; Rossavik IK; Findley WE
J Reprod Med; 1987 May; 32(5):359-62. PubMed ID: 3598984
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of ovarian response to stimulation in in-vitro fertilization cycles.
Kerin JF; Warnes GM
Clin Obstet Gynecol; 1986 Mar; 29(1):158-70. PubMed ID: 3082553
[No Abstract] [Full Text] [Related]
11. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
[TBL] [Abstract][Full Text] [Related]
12. Bilateral ovarian pregnancy after in vitro fertilization and embryo transfer in a patient with tubal factor infertility.
Han M; Kim J; Kim H; Je G; Hwang T
J Assist Reprod Genet; 2004 May; 21(5):181-3. PubMed ID: 15279326
[TBL] [Abstract][Full Text] [Related]
13. [Acupuncture combined with medication improves endocrine hormone levels and ovarian reserve function in poor ovarian response patients undergoing in vitro fertilization-embryo transplantation].
Dong XL; Ran JK; Zhang HJ; Chen K; Li HX
Zhen Ci Yan Jiu; 2019 Aug; 44(8):599-604. PubMed ID: 31475495
[TBL] [Abstract][Full Text] [Related]
14. Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles.
Lindheim SR; Cohen MA; Chang PL; Sauer MV
J Assist Reprod Genet; 1999 May; 16(5):242-6. PubMed ID: 10335470
[TBL] [Abstract][Full Text] [Related]
15. Low- versus high-dose human menopausal gonadotropin in an in vitro fertilization-embryo transfer program.
Levy T; Ben-Rafael Z
J Assist Reprod Genet; 1995 Apr; 12(4):235-8. PubMed ID: 7580018
[No Abstract] [Full Text] [Related]
16. A model to show human uterine receptivity and embryo viability following ovarian stimulation for in vitro fertilization.
Rogers PA; Milne BJ; Trounson AO
J In Vitro Fert Embryo Transf; 1986 Apr; 3(2):93-8. PubMed ID: 3701185
[TBL] [Abstract][Full Text] [Related]
17. Poor responders to ovarian hyperstimulation may benefit from an attempt at natural-cycle oocyte retrieval.
Lindheim SR; Vidali A; Ditkoff E; Sauer MV; Zinger M
J Assist Reprod Genet; 1997 Mar; 14(3):174-6. PubMed ID: 9090562
[No Abstract] [Full Text] [Related]
18. Higher rates of aneuploidy in blastocysts and higher risk of no embryo transfer in recurrent pregnancy loss patients with diminished ovarian reserve undergoing in vitro fertilization.
Shahine LK; Marshall L; Lamb JD; Hickok LR
Fertil Steril; 2016 Oct; 106(5):1124-1128. PubMed ID: 27371114
[TBL] [Abstract][Full Text] [Related]
19. Follicular output rate tends to improve clinical pregnancy outcomes in patients with polycystic ovary syndrome undergoing
Tan X; Wen Y; Chen H; Zhang L; Wang B; Wen H; Zhang F; Wu Q; Du J
J Int Med Res; 2019 Oct; 47(10):5146-5154. PubMed ID: 31379237
[TBL] [Abstract][Full Text] [Related]
20. Oocyte and embryo quality in patients with excessive ovarian response during in vitro fertilization treatment.
Ng EH; Lau EY; Yeung WS; Ho PC
J Assist Reprod Genet; 2003 May; 20(5):186-91. PubMed ID: 12812461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
